247 related articles for article (PubMed ID: 26445852)
1. Genetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-Analysis.
Findlay JM; Middleton MR; Tomlinson I
Dig Dis Sci; 2016 Jan; 61(1):25-38. PubMed ID: 26445852
[TBL] [Abstract][Full Text] [Related]
2. Identification and clinical implementation of biomarkers for Barrett's esophagus.
Varghese S; Lao-Sirieix P; Fitzgerald RC
Gastroenterology; 2012 Mar; 142(3):435-441.e2. PubMed ID: 22266150
[No Abstract] [Full Text] [Related]
3. Barrett's esophagus: is dysplasia a reliable marker in surveillance after endoscopic treatment?
Ortner MA
Curr Gastroenterol Rep; 2001 Oct; 3(5):371-4. PubMed ID: 11560793
[No Abstract] [Full Text] [Related]
4. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma.
Hillman LC; Chiragakis L; Clarke AC; Kaushik SP; Kaye GL
J Gastroenterol Hepatol; 2003 May; 18(5):526-33. PubMed ID: 12702044
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus.
Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
[TBL] [Abstract][Full Text] [Related]
9. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.
Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J
J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Yang H; Gu J; Wang KK; Zhang W; Xing J; Chen Z; Ajani JA; Wu X
Clin Cancer Res; 2009 Sep; 15(18):5744-52. PubMed ID: 19737949
[TBL] [Abstract][Full Text] [Related]
11. Common Variants Confer Susceptibility to Barrett's Esophagus: Insights from the First Genome-Wide Association Studies.
Palles C; Findlay JM; Tomlinson I
Adv Exp Med Biol; 2016; 908():265-90. PubMed ID: 27573776
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers and genetics in cancer development.
Hormi-Carver K; Souza RF
Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
14. Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.
Varghese S; Newton R; Ross-Innes CS; Lao-Sirieix P; Krishnadath KK; O'Donovan M; Novelli M; Wernisch L; Bergman J; Fitzgerald RC
Gastroenterology; 2015 Nov; 149(6):1511-1518.e5. PubMed ID: 26248086
[TBL] [Abstract][Full Text] [Related]
15. Management of cancer risk in Barrett's esophagus.
Tan A; Macrae F
J Gastroenterol Hepatol; 2011 Oct; 26(10):1485-92. PubMed ID: 21592226
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.
Ong CA; Lao-Sirieix P; Fitzgerald RC
World J Gastroenterol; 2010 Dec; 16(45):5669-81. PubMed ID: 21128316
[TBL] [Abstract][Full Text] [Related]
17. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.
Del Portillo A; Lagana SM; Yao Y; Uehara T; Jhala N; Ganguly T; Nagy P; Gutierrez J; Luna A; Abrams J; Liu Y; Brand R; Sepulveda JL; Falk GW; Sepulveda AR
J Mol Diagn; 2015 Jul; 17(4):412-9. PubMed ID: 26068095
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers for Barrett's esophagus and its progression to cancer.
Fels Elliott DR; Fitzgerald RC
Curr Opin Gastroenterol; 2013 Jul; 29(4):437-45. PubMed ID: 23689523
[TBL] [Abstract][Full Text] [Related]
20. Still waiting for predictive biomarkers in Barrett's oesophagus.
Moyes LH; Going JJ
J Clin Pathol; 2011 Sep; 64(9):742-50. PubMed ID: 21606229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
